Advances in the pharmacotherapy of Heart Failure: type 2 sodium-glucose cotransporter Inhibitors (SGLT2) as a therapeutic option. RSD [Internet]. 2023 Mar. 1 [cited 2026 Jan. 2];12(3):e12412340502. Available from: https://www.rsdjournal.org/rsd/article/view/40502